Huimin Wang - Jul 8, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, Japan & Intercontinental
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jul 8, 2022
Transactions value $
-$229,332
Form type
4
Date filed
7/8/2022, 06:21 PM
Previous filing
Jun 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $129K +3.68K +3.7% $35.20 103K Jul 8, 2022 Direct F1
transaction EW Common Stock Sale -$359K -3.68K -3.57% $97.60 99.4K Jul 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -3.68K -12.5% $0.00 25.7K Jul 8, 2022 Common Stock 3.68K $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.